Kartik C. Anand
Expertise in
33
conditions

Dr. Kartik C. Anand

Hematology Oncology
200 E. Ridgeway Ave., 
Waterloo, IA 
Accepting New Patients
Expertise in
33
conditions
200 E. Ridgeway Ave., 
Waterloo, IA 

Overview

Kartik Anand, MD, specializes in Hematology Oncology at MercyOne Waterloo Cancer Care.

Dr. Anand is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Lung Cancer, Triple-Negative Breast Cancer, and Breast Cancer.

He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 2 clinical trials. Dr. Anand is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in IA

Hospital Affiliations

Unitypoint Health - Des Moines Iowa Methodist Medi
Mercyone Waterloo Medical Center
Mercyone Des Moines Medical Center
Mary Lanning Healthcare

Languages Spoken

English
Hindi
Punjabi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 15 Less Insurance Carriers -

Locations

MercyOne Waterloo Cancer Care
200 E. Ridgeway Ave., Waterloo, IA 50702

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drug: KPT-8602
Study Phase: Phase 1/Phase 2
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Pembrolizumab
Study Phase: Phase 2
View 1 Less Clinical Trial

30 Total Publications

TCF3::PBX1 fusion pediatric B acute lymphoblastic leukemia in disguise behind the eyes - an unusual clinicopathologic presentation with hyperdiploid clone.
TCF3::PBX1 fusion pediatric B acute lymphoblastic leukemia in disguise behind the eyes - an unusual clinicopathologic presentation with hyperdiploid clone.
Journal: Leukemia & lymphoma
Published: February 26, 2024
Similar Doctors
Expertise in
40
conditions
Dr. Hussain M. Naseri
Hematology Oncology
Expertise in
40
conditions
Dr. Hussain M. Naseri
Hematology Oncology
Referral may be required

MercyOne Waterloo Hematology Oncology

200 E. Ridgeway Ave., 
Waterloo, IA 
 (0.1 miles away)
319-272-2070
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Hussain Naseri is a Hematologist Oncology provider practicing medicine in Waterloo, Iowa. Dr. Naseri is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Childhood Iron Deficiency Anemia. Dr. Naseri is board certified in American Board Of Internal Medicine. Dr. Naseri is currently accepting new patients.

Expertise in
1
conditions
Kathryn A. Heetland, NP
Hematology Oncology | Oncology
Expertise in
1
conditions
Kathryn A. Heetland, NP
Hematology Oncology | Oncology
Referral may be required

MercyOne Waterloo Cancer Care

200 E. Ridgeway Ave., 
Waterloo, IA 
 (0.1 miles away)
319-272-2800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

My goal is to care for my patients in the same manner as I would want care provided for myself or for my family. I strive to be timely with appointments. I work to provide quality care with empathy and compassion. I try to find something to help patient's smile even as they deal with a difficult illness. Dr. Heetland is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Porphyria Cutanea Tarda, and Severe Congenital Neutropenia. Dr. Heetland is board certified in American Nurses Credentialing Center. Dr. Heetland is currently accepting new patients.

Expertise in
2
conditions
Natalie A. Bloom, NP
Hematology Oncology
Expertise in
2
conditions
Natalie A. Bloom, NP
Hematology Oncology
Referral may be required

MercyOne Waterloo Hematology Oncology

200 E. Ridgeway Ave., 
Waterloo, IA 
 (0.1 miles away)
319-272-2070
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Natalie Bloom is a Hematologist Oncology provider practicing medicine in Waterloo, Iowa. Dr. Bloom is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Acute Mountain Sickness, and Breast Cancer. Dr. Bloom is currently accepting new patients.

Frequently Asked Questions about Dr. Kartik C. Anand

How do I make an appointment with Dr. Kartik C. Anand?

You can book an appointment with Dr. Kartik C. Anand by calling their office at 319-272-2800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kartik C. Anand a top-rated expert for Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kartik C. Anand is classified as an Advanced expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kartik C. Anand specialize in?

While Dr. Kartik C. Anand is a Hematology Oncology, they have specific expertise in Thrombocytopenia, Lung Cancer, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Kartik C. Anand participate in research or clinical trials?

Yes. Dr. Kartik C. Anand has published 30 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Dr. Kartik C. Anand's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kartik C. Anand accept my insurance?

Dr. Kartik C. Anand accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 319-272-2800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anand's expertise for a condition
ConditionClose
      View All 33 Advanced Conditions
      View All 179 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile